Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05640843
What this trial is testing

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 180
Not applicableUnknownNCT02933021
What this trial is testing

Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

Who this might be right for
Monoclonal Gammopathy of Unknown Significance
RxCelerate Ltd 664
Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT00665652
What this trial is testing

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
NeuropathyNonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Dartmouth-Hitchcock Medical Center 8
Not applicableStudy completedNCT05119309
What this trial is testing

MGRS: Clinical-histological Features of a Multicenter Case Series

Who this might be right for
Monoclonal Gammopathy of Renal Significance
University of Milano Bicocca 87
Not applicableLooking for participantsNCT06895291
What this trial is testing

Whole Body MRI in Oncology

Who this might be right for
LymphomaAdvanced Prostate CancerAdvanced Breast Cancer+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,000
Testing effectiveness (Phase 2)Study completedNCT04731844
What this trial is testing

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Who this might be right for
Prostate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)+1 more
University of Rochester 30
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Testing effectiveness (Phase 2)UnknownNCT05114109
What this trial is testing

Isatuximab in Type I Cryoglobulinemia

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceCryoglobulinemic Vasculitis
Assistance Publique - Hôpitaux de Paris 21
Not applicableLooking for participantsNCT06055894
What this trial is testing

A Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Who this might be right for
Multiple Myeloma, SmolderingMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Memorial Sloan Kettering Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Not applicableLooking for participantsNCT05686447
What this trial is testing

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

Who this might be right for
Monoclonal GammopathiesMultiple MyelomaM-protein
Zhujiang Hospital 200
Not applicableStudy completedNCT00933296
What this trial is testing

Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors

Who this might be right for
Schnitzler Syndrome
University Hospital, Strasbourg, France 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Next Page